Other Information
+Added: Table of Content
The exhibits listed below are filed or furnished as part of this report.
Number Description
−Removed: Letter Agreement between the Company and A.
−Removed: Ernest Toth, Jr.
−Removed: , effective on June 15, 2021.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).
10 unchanged sentences
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
+Added: Table of Content
Pursuant to the requirements of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the County of Somerset, State of New Jersey.
Aquestive Therapeutics, Inc.
−Removed: August 3, 2021 /s/ Keith J.
+Added: November 2, 2021 /s/ Keith J.
President and Chief Executive Officer
(Principal Executive Officer)
−Removed: August 3, 2021 /s/ A.
+Added: November 2, 2021 /s/ A.
Ernest Toth, Jr.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.